University medical school accepts tobacco company fundingBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39147.388194.DB (Published 08 March 2007) Cite this as: BMJ 2007;334:496
- Lynn Eaton
A string of medical experts have lined up to criticise the decision by the University of Virginia School of Medicine to accept funding for medical research from tobacco company Philip Morris—to the tune of $20m.
The American Medical Association, the American Public Health Association, and the editor of the academic journal Tobacco have all condemned the news.
“A medical school taking funding from the tobacco industry is like a peace studies school taking funding from terrorists,” said Tobacco Control's editor Simon Chapman, professor of public health at the University of Sydney.
Georges Benjamin, executive director of the American Public Health Association, said he too was against the move.
“There is a growing body of evidence that this kind of arrangement results in biased studies in favour of the funder”. The real reason he suspects the tobacco industry does this is to help their image and improve the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial